Detalhe da pesquisa
1.
Efficacy of etanercept in the tumor necrosis factor receptor-associated periodic syndrome: a prospective, open-label, dose-escalation study.
Arthritis Rheum
; 64(3): 908-13, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22006113
2.
Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study.
Arthritis Rheum
; 62(2): 542-52, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20112381
3.
Abnormal differentiation of memory T cells in systemic lupus erythematosus.
Arthritis Rheum
; 54(7): 2184-97, 2006 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16802356
4.
Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus.
Arthritis Rheum
; 54(8): 2505-14, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16868971
5.
Identification and characterization of circulating human transitional B cells.
Blood
; 105(11): 4390-8, 2005 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15701725
6.
A pilot study of the use of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography to assess the distribution of activated lymphocytes in patients with systemic lupus erythematosus.
Arthritis Rheum
; 50(4): 1233-8, 2004 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15077306
7.
Cytochrome P450 pharmacogenetics as a predictor of toxicity and clinical response to pulse cyclophosphamide in lupus nephritis.
Arthritis Rheum
; 50(7): 2202-10, 2004 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-15248218